Table 3.
Original Lyon 1.0 criteria | Updated Lyon 2.0 criteria | Retired criteria | |
Overall | Concepts of different testing strategies in unproven versus proven GERD | ||
Endoscopy | No criteria for endoscopy performed on therapy | Separate criteria added for testing performed on therapy | |
Conclusive endoscopic evidence off therapy | LA C, D oesophagitis | LA B, C, D oesophagitis | |
Borderline endoscopic evidence off therapy | LA A, B oesophagitis | LA A ooesophagitis | |
Adjunctive endoscopic evidence off therapy | Histopathology (score) Electron microscopy (DIS) Low mucosal impedance |
Hiatus hernia Histopathology scoring systems Electron microscopy of biopsies |
Routine oesophageal biopsy analysis Endoscopy-based mucosal impedance assessment |
pH or pH impedance | No separation between testing off and on antisecretory therapy | Separate thresholds for testing off and on antisecretory therapy | |
wireless pH monitoring | No criteria for wireless pH monitoring | Wireless monitoring thresholds added | |
pH impedance monitoring | No thresholds for baseline impedance | Thresholds added for mean nocturnal baseline impedance | Postreflux swallow induced peristaltic wave index |
High-resolution manometry | Analysis of motor diagnoses using Chicago Classification version 3.0 | Analysis of motor diagnoses using Chicago Classification version 4.0 |
DIS, dilated intercellular spaces; GERD, gastro-oesophageal reflux disease; LA, Los Angeles.